Clinical Trial Update: A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the analgesic efficacy of AZD2423 versus placebo after 28 days in patients with painful diabetic polyneuropathy; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• AZD2423

Snippet

Sponsor: AstraZeneca | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-09-25